Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: Hemp

Rocky Mountain High Brands Brings Amazon Fulfillment of Beverages In-House

DALLAS, Feb. 16, 2017 (GLOBE NEWSWIRE) — Rocky Mountain High Brands, Inc. (OTCQB:RMHB), a fully reporting consumer goods company specializing in hemp-infused food and beverage products and a naturally high alkaline water announced today it has taken over management of its Amazon fulfillment. All hemp-infused beverages are now available on Amazon.com and will be serviced by Rocky Mountain High Brands personnel.

Michael Welch, President and Chief Executive Officer of Rocky Mountain High Brands, Inc., stated, “By bringing our Amazon fulfillment in-house, we are able to ensure that our Amazon customers receive the same high level of customer service that our own www.liverockymountainhigh.com customers receive. Taking control of our fulfillment will allow us to expand our product line to include variety packs of our hemp-infused beverages, hemp-infused energy shots and our high-alkaline spring water.”

Welch added, “The Company recently posted its second quarter financial results. Of note to our investors, when …

Continue Reading

Posted in Client News| Tagged , |

MJNA Starts Where it Left off in 2016 with Big International Growth

HempMeds

To say that Medical Marijuana, Inc. made headlines in 2016 would be an understatement. In reality, the company known for its CBD hemp oil products took the medical marijuana market by storm with product availability in all 50 states. Since its launch in 2012, MJNA‘s subsidiary company, HempMeds, has made it easier for patients around the country to access relief for a variety of medical issues without the debilitating side effects that often accompany traditional treatment methods. In 2015, the market for hemp products in the United States climbed to $573 million, and that figure is expected to increase dramatically over the next several years. According to estimates from the Hemp Business Journal, the market for CBD is expected to reach $2.1 billion by 2020.

MJNA’s Subsidiary Companies

MJNA‘s subsidiaries include HempMeds, Kannaway, HempMeds MX and HempMeds Brasil. Each of these subsidiaries serves a unique segment of the cannabis …

Continue Reading

Posted in Articles| Tagged , , , , |

ChineseInvestors.com (OTCQB: CIIX), Announces the Launch of its New Website for its New Subsidiary ChineseCBDoil.com

NEW YORK, February 1, 2017 /PRNewswire/ — ChineseInvestors.com (OTCQB: CIIX), is pleased to announce the launch of its new website for its new subsidiary ChineseCBDoil.com. The website went live on January 31st under the URL: http://www.ChineseCBDoil.com. The Company is expanding into the medical marijuana industry with the launch of its website and plans to retail hemp oil and related products, which are legal to sell and distribute within China and in the United States in all fifty states (hemp oil is not marijuana, but indeed a separate and distinct plant made from hemp). CBD oil, derived from hemp is a product with medicinal qualities that are primarily used for anti-inflammatory and other common ailments. Its website is intended for the Chinese speaking population, a global market of 2 Billion people.

Mr. Warren Wang, the Chairman of ChineseInvestors.com stated: “I am very pleased to see the investor reaction to our announced …

Continue Reading

Posted in Client News| Tagged , , |

1-30-17 SmallCapVoice Interview with Chineseinvestors.com, Inc. (CIIX)

Chineseinvestors.com, Inc. (CIIX)

Alan Klitenic, director of Investor Relations for ChineseInvestors.com (OTCQB: CIIX) (the “Company”), called in to SmallCapVoice.com, Inc. to go over the business model, markets, milestones and 2017 outlook for the Company. Founded in 1999, ChineseInvestors.com, Inc. endeavors to be an innovative company providing (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) support services to various partners; (c) consultative services to smaller private companies considering becoming a public company; (d) advertising and public relation related support services; and (e) other services we may identify having the potential to create value or partnership opportunity with our existing services. Recently, the Company announced a new wholesale agreement that enables CIIX to retail nutritional supplements containing CBD to the Asian market through both online and in-store sales. The CBD company’s flagship product is the top-selling brand of hemp-derived CBD oil for consumers in …

Continue Reading

Posted in Interviews| Tagged , , |

ChineseInvestors.com, Inc. (CIIX) Engages NetworkNewsWire for Corporate Communications Solutions

NEW YORK, NY–(Marketwired – Jan 25, 2017) – ChineseInvestors.com, Inc. (the “Company”) (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors in both the U.S. and China, announces that it has engaged the expertise of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. NNW’s solutions help public and private organizations find their voice and build market visibility via social media and a rapidly expanding distribution network of well over 5,000 key syndication outlets.

“ChineseInvestors.com has a strong history of providing investment-based education products and services. We are now taking significant strides to expand our operations and capitalize on the lucrative growth of the cannabis industry with the upcoming and previously announced launch of www.ChineseCBDoil.com,” says Warren Wang, founder and CEO of CIIX. “This is an opportunity we certainly do not …

Continue Reading

Posted in Client News| Tagged , , |

MJTV Engages Dr. Gregory Smith As Chief Medical Advisor

WHIPPANY, NJ–(Marketwired – Jan 25, 2017) – Michael James Enterprises, Inc. (OTCQB: MJTV) is extremely pleased to bring on Gregory Smith, M.D. as Chief Medical Advisor to consult with MJTV on the Voluptas Project as well the different Neuroceuticals the Company has under development.

Dr. Smith earned his medical degree from Rush Medical School in Chicago as well as his Master of Public Health from Harvard University. He completed residency training in Preventive Medicine at Walter Reed Army Medical Center. Since leaving the US Army with the rank of Major, Doctor Smith has been in primary Practice care in California, Georgia and Florida for the past 25 plus years.

Doctor Smith trained on the use of cannabinoid pharmaceuticals in California in 2000, and has consulted with several biosynthetic cannabinoid manufacturers over past four years. Dr. Smith wrote “Medical Cannabis: Basic Science and Clinical Applications,” in 2016 published by Aylesbury Press. …

Continue Reading

Posted in Client News| Tagged , , , |